As expected for an oncogene candidate, MTHFD2 levels was found increased in other types of cancer, such as colorectal cancer [35], urothelial carcinoma [37], breast cancer [38], esophageal squamous cell carcinoma [39], as well as lung adenocarcinoma [40]. This evidence concerns the gene MTHFD2 and breast cancer.